UBS has downgraded BHEL to "Neutral" from "Buy", citing a more balanced risk-reward outlook after the stock's strong run, though it raised the target price to Rs 460 from Rs 375, implying about 14% upside. The brokerage believes much of BHEL's order book growth is already reflected in the stock price.
Market Samachar is a news aggregator. This article was originally published by Stocks-Markets-Economic Times. Tap the button above to read the full story on their site.